Metraipolis › archive › dc_41f6ad5ef00a

Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a… — Europe PMC PMID:40918505

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40918505
DOI: 10.3389/fphar.2025.1584612
License (as archived): solo-consultazione
Archived: 2026-11-10T10:07:53.757Z
SHA-256 of the archived text: a0760557339d65a7596476f5f85506c9fdb4e4484310008a2c431dbd999e496c
Stable URL of this page: https://metraipolis.com/documento/dc_41f6ad5ef00a

How to cite

Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a… — Europe PMC PMID:40918505 — Europe PMC (en), https://europepmc.org/article/MED/40918505 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_41f6ad5ef00a (Metraipolis archive dc_41f6ad5ef00a, sha256 a0760557339d65a7596476f5f85506c9fdb4e4484310008a2c431dbd999e496c)

BibTeX

@misc{dc41f6ad5ef00a,
  title = {Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a… — Europe PMC PMID:40918505},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40918505},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_41f6ad5ef00a; sha256 a0760557339d65a7596476f5f85506c9fdb4e4484310008a2c431dbd999e496c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40918505. Agents can read the archived copy with the MCP tool read_document.